| 000 | 01371 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517175054.0 | ||
| 264 | 0 | _c20180523 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a2405-8025 | ||
| 024 | 7 |
_a10.1016/j.trecan.2017.08.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHarmeyer, Kayla M | |
| 245 | 0 | 0 |
_aJARID1 Histone Demethylases: Emerging Targets in Cancer. _h[electronic resource] |
| 260 |
_bTrends in cancer _c10 2017 |
||
| 300 |
_a713-725 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aBiomarkers, Tumor |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJumonji Domain-Containing Histone Demethylases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aMultigene Family |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aTranscription, Genetic |
| 700 | 1 | _aFacompre, Nicole D | |
| 700 | 1 | _aHerlyn, Meenhard | |
| 700 | 1 | _aBasu, Devraj | |
| 773 | 0 |
_tTrends in cancer _gvol. 3 _gno. 10 _gp. 713-725 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.trecan.2017.08.004 _zAvailable from publisher's website |
| 999 |
_c27612281 _d27612281 |
||